Fig. 1From: Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation studyPatient flow and disposition. Two patients died during screening; three patients died after enrollment, all of whom received four or fewer doses of sebelipase alfaBack to article page
